 |
 |
|
 |
| In recent years, Genemed Biotechnologies,
Inc. has recruited a team of talented scientists to form a strong
Research and Development (R&D) team, who's dedication and
innovation has successfully developed its own proprietary technologies.
The two core technologies: the Gene Enrichment Technology (GET;
patented) and the Full-length Low Abundant Gene Subtraction
(FLAGS; patent pending) have established a new platform (GET-FLAGS)
for its internal rapid gene drug candidate discovery program.
The byproducts generated by these proprietary technologies,
such as: GETRare™ and GETLarge™ product lines (total
of 71 products), have also successfully been released to the
market to provide research tools that allow academic and industrial
scientists to simplify their projects and accelerate their discoveries. |
|
|
|
|
|